Abstract:Background: Early identification of vulnerable plaques is important for patients with coronary artery disease (CAD) to reduce acute coronary events and improve their prognosis. We sought to examine the relationship between adipsin, an adipokine secreted from adipocytes, and plaque vulnerability in CAD patients. Methods: A total of 103 plaques from 99 consecutive patients who underwent coronary angiography were assessed by optical coherence tomography. The serum level of adipsin was measured using enzyme-linked immunosorbent assay (ELISA). The accuracy of adipsin for detecting thin-cap fibroatheroma (TCFA) was determined by the area under the receiver operating characteristic curve (AUC). Results: Of the 99 patients, 49 were classified into the low adipsin group and 50 into the high adipsin group according to the median level of serum adipsin (2.43 mu g/mL). The plaques from the high adipsin group exhibited a greater lipid index (2,700.0 vs. 1,975.9 degrees x mm, P=0.015) and an increased proportion of TCFAs (41.2% vs. 21.2%, P=0.028) compared with the low adipsin group. Serum adipsin was found to be negatively correlated with fibrous cap thickness (rho=-0.322, P=0.002), while it was positively correlated with average lipid arc (rho=0.253, P=0.015), maximum lipid arc (rho=0.211, P=0.044), lipid core length (rho=0.241, P=0.021), lipid index (rho=0.335, P=0.001), and vulnerability score (rho=0.254, P=0.014). Furthermore, adipsin had a significant association with TCFAs (OR: 1.290, 95% CI: 1.048-1.589, P=0.016) in the multivariate analysis, while having a moderate diagnostic accuracy for TCFAs (AUC: 0.710, 95% CI: 0.602-0.817, P<0.001). Conclusions: Our findings suggest that serum adipsin is significantly and positively correlated with the incidence of TCFAs. The application of adipsin as a biomarker may offer improvement in the diagnosis of vulnerable plaques and clinical benefits for CAD patients.

Relationship Between Plasma Adiponectin Levels and Fibrinolytic Activities in Patients with Coronary Heart Disease

Clinical Significance of the Changes of Plasma Adiponectin Levels in Patients with Coronary Artery Disease

The Relationship of Homocysteine Levels to Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Acute Coronary Syndrome Patients

Importance of Fibrinolytic Activity in Patients with Coronary Artery Diseases

Adiponectin Levels Are Associated with the Number and Activity of Circulating Endothelial Progenitor Cells in Patients with Coronary Artery Disease

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Association Between Plasma Lysophosphatidic Acid and Coronary Stenosis with Coronary Heart Disease

Correlation between plasma adiponectin level and complement C3 expression in patients with coronary heart disease

[Association Between Plasma Adiponectin Levels and Coronary Lesion Complexity].

Relationship between serum adiponectin and coronary heart disease

The Research of Serum Adiponectin Levels in Male Patients with Coronary Heart Disease

[The Relationship Between Adiponectin and Coronary Heart Disease Metabolic Risk Factors in Non-Diabetic Male Patients].

Correlation of Serum Adipolin with Epicardial Fat Thickness and Severity of Coronary Artery Diseases in Acute Myocardial Infarction and Stable Angina Pectoris Patients

The Relationship Between Serum Level of Adiponectin and Severity of Coronary Artery Stenosis

Association Between Serum Adipsin and Plaque Vulnerability Determined by Optical Coherence Tomography in Patients with Coronary Artery Disease

Relationship between Decreased Plasma Adiponectin and Severity of Coronary Artery Lesions in Patients with Type-2 DM and Chronic Stable Angina Pectoris

Study on the relationship between coronary artery lesions an d plasma fibrinogen

Decreased Plasma Apolipoprotein A-Iv Levels in Patients with Acute Coronary Syndrome

An observational study on aortic plasma levels of angiotensin II and plasminogen activator inhibitor-1 in patients with coronary artery stenosis

Correlation Between Plasma Asymmetric Dimethylarginine and Different Types of Coronary Heart Disease

Relationship between serum angiotension-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with myocardial infarction